25 junio 2015
Investigators harnessed genomic data to discover that the previously identified E2F4 signature in breast cancer can be utilized to predict prognosis and response to therapy in bladder cancer.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/nuQbJSoDSdM/150625112908.htm
